تكشف تحليلات استقصاء السوق الحديثة التي قادها نشطاء الصحة المجتمعية في كينيا، مالاوي، وأوغندا عن تحديات هيكلية تعرقل الوصول المنصف والمستدام إلى الأدوية المنقذة للحياة، وتشمل هذه التحديات: عدم الكفاءة في نظم الشراء، الاعتماد
Terms of Reference (ToR) for ConsultationDemand Creation for New Generation ARVs – Acceptance Study Among PLWHIV 1. Context and Justification The Middle East and North Africa (MENA) region faces a growing HIV epidemic, characterized
Joint press release FOR IMMEDIATE RELEASE MENA-H coalition urges urgent action to combat tuberculosis in the region, with emphasis on innovation and universal health coverage 2025, March 24 – On World Tuberculosis Day, the
We are excited to announce a fantastic opportunity for our community members in the MENA region. ITPC-MENA launched a call for scholarships “available for two to three deserving candidates to participate in the prestigious
A study was carried out by the FORSS consortium which includes (ITPC-MENA, Solidarité SIDA, AGD, ATP+, Al Shehab RdR Maroc, and M-Coalition). This recently developed report analyzes the impact of the COVID-19 pandemic on
Since the beginning of the HIV epidemic, Community Advisory Boards (CABs) constituted an effective tool to link communities as real partners with researchers and drug manufacturers; educate people living with HIV and their advocates,
The Empowering Activists Program is a training initiative aimed at empowering and empowering activists in the MENA region to take action for better health. The aim is to help activists to: • Acquire the
In the MENA region, there have been significant changes in the management of Global Fund grants such as recent portfolio allocations and CCM elections. In addition, many countries in the MENA region are currently
ITPC-MENA is pleased to inform you that Mr. Othmane MARRAKCHI has recently joined ITPC-MENA as Advocacy Officer for Access to Medicines. In this position, Mr. Othmane MARRAKCHI will manage the development and implementation of
A new US$ 7.5 million programme to strengthen sustainable access to HIV prevention, treatment, and care for marginalised groups in the Middle East and North Africa has been approved by the board of the
